Methodological issues in meta-analyses of real-world clinical data to infer causality

Alicia Uijl; Lars H Lund; Folkert W Asselbergs; Gianluigi Savarese

doi:10.1016/j.ijcard.2021.10.029

Methodological issues in meta-analyses of real-world clinical data to infer causality

Alicia Uijl, Lars H Lund, Folkert W Asselbergs, Gianluigi Savarese

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	107-108
Number of pages	2
Journal	International Journal of Cardiology
Volume	345
DOIs	https://doi.org/10.1016/j.ijcard.2021.10.029
Publication status	Published - 15 Dec 2021

Keywords

Aminobutyrates
Humans
Stroke Volume

Access to Document

10.1016/j.ijcard.2021.10.029

Cite this

@article{35ad94a96e2b4bdaab04aced03c614f4,

title = "Methodological issues in meta-analyses of real-world clinical data to infer causality",

keywords = "Aminobutyrates, Humans, Stroke Volume",

author = "Alicia Uijl and Lund, {Lars H} and Asselbergs, {Folkert W} and Gianluigi Savarese",

note = "Funding Information: LHL reports personal fees from Merck, personal fees from Sanofi, grants and personal fees from Vifor-Fresenius , grants and personal fees from AstraZeneca , grants and personal fees from Relypsa , personal fees from Bayer, grants from Boston Scientific , personal fees from Pharmacosmos, personal fees from Abbott, grants and personal fees from Mundipharma , personal fees from Medscape, personal fees from Myokardia, grants and personal fees from Boehringer Ingelheim , grants and personal fees from Novartis , outside the submitted work. Funding Information: FWA is supported by UCL Hospitals NIHR Biomedical Research Centre . Funding Information: LHL reports personal fees from Merck, personal fees from Sanofi, grants and personal fees from Vifor-Fresenius, grants and personal fees from AstraZeneca, grants and personal fees from Relypsa, personal fees from Bayer, grants from Boston Scientific, personal fees from Pharmacosmos, personal fees from Abbott, grants and personal fees from Mundipharma, personal fees from Medscape, personal fees from Myokardia, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, outside the submitted work.FWA is supported by UCL Hospitals NIHR Biomedical Research Centre.GS reports grants and personal fees from Vifor, grants and non-financial support from Boehringer Ingelheim, personal fees from Societa? Prodotti Antibiotici, grants and personal fees from AstraZeneca, personal fees from Roche, personal fees from Servier, grants from Novartis, personal fees from GENESIS, personal fees from Cytokinetics, personal fees from Medtronic, grants from Boston Scientific, grants from PHARMACOSMOS, grants from Merck, outside the submitted work. Funding Information: GS reports grants and personal fees from Vifor , grants and non-financial support from Boehringer Ingelheim , personal fees from Societa´ Prodotti Antibiotici, grants and personal fees from AstraZeneca , personal fees from Roche, personal fees from Servier, grants from Novartis , personal fees from GENESIS, personal fees from Cytokinetics, personal fees from Medtronic, grants from Boston Scientific , grants from PHARMACOSMOS , grants from Merck , outside the submitted work.",

year = "2021",

month = dec,

day = "15",

doi = "10.1016/j.ijcard.2021.10.029",

language = "English",

volume = "345",

pages = "107--108",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Methodological issues in meta-analyses of real-world clinical data to infer causality

AU - Uijl, Alicia

AU - Lund, Lars H

AU - Asselbergs, Folkert W

AU - Savarese, Gianluigi

N1 - Funding Information: LHL reports personal fees from Merck, personal fees from Sanofi, grants and personal fees from Vifor-Fresenius , grants and personal fees from AstraZeneca , grants and personal fees from Relypsa , personal fees from Bayer, grants from Boston Scientific , personal fees from Pharmacosmos, personal fees from Abbott, grants and personal fees from Mundipharma , personal fees from Medscape, personal fees from Myokardia, grants and personal fees from Boehringer Ingelheim , grants and personal fees from Novartis , outside the submitted work. Funding Information: FWA is supported by UCL Hospitals NIHR Biomedical Research Centre . Funding Information: LHL reports personal fees from Merck, personal fees from Sanofi, grants and personal fees from Vifor-Fresenius, grants and personal fees from AstraZeneca, grants and personal fees from Relypsa, personal fees from Bayer, grants from Boston Scientific, personal fees from Pharmacosmos, personal fees from Abbott, grants and personal fees from Mundipharma, personal fees from Medscape, personal fees from Myokardia, grants and personal fees from Boehringer Ingelheim, grants and personal fees from Novartis, outside the submitted work.FWA is supported by UCL Hospitals NIHR Biomedical Research Centre.GS reports grants and personal fees from Vifor, grants and non-financial support from Boehringer Ingelheim, personal fees from Societa? Prodotti Antibiotici, grants and personal fees from AstraZeneca, personal fees from Roche, personal fees from Servier, grants from Novartis, personal fees from GENESIS, personal fees from Cytokinetics, personal fees from Medtronic, grants from Boston Scientific, grants from PHARMACOSMOS, grants from Merck, outside the submitted work. Funding Information: GS reports grants and personal fees from Vifor , grants and non-financial support from Boehringer Ingelheim , personal fees from Societa´ Prodotti Antibiotici, grants and personal fees from AstraZeneca , personal fees from Roche, personal fees from Servier, grants from Novartis , personal fees from GENESIS, personal fees from Cytokinetics, personal fees from Medtronic, grants from Boston Scientific , grants from PHARMACOSMOS , grants from Merck , outside the submitted work.

PY - 2021/12/15

Y1 - 2021/12/15

KW - Aminobutyrates

KW - Humans

KW - Stroke Volume

U2 - 10.1016/j.ijcard.2021.10.029

DO - 10.1016/j.ijcard.2021.10.029

M3 - Comment/Letter to the editor

C2 - 34688720

SN - 0167-5273

VL - 345

SP - 107

EP - 108

JO - International Journal of Cardiology

JF - International Journal of Cardiology

ER -